Leqembi
Payments companies reported to CMS as associated with Leqembi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Leqembi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Leqembi
These are the largest totals companies reported as associated with Leqembi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Daniel Weintraub | Philadelphia, PA | Psychiatry | $296,660.34 |
| John Hemphill | Savannah, GA | Neurology With Special Qualifications In Child Neurology | $266,617.59 |
| John Bertelson | Austin, TX | Behavioral Neurology & Neuropsychiatry | $243,963.68 |
| Paul Schulz | Houston, TX | Behavioral Neurology & Neuropsychiatry | $242,085.33 |
| Armen Moughamian | San Francisco, CA | Neurology (Psychiatry & Neurology) | $209,980.53 |
| Wendell Helveston | Jackson, MS | Neurology (Psychiatry & Neurology) | $204,354.56 |
| Adam Wolff | Denver, CO | Neurology (Psychiatry & Neurology) | $185,235.82 |
| David Weisman | Abington, PA | Neurology (Psychiatry & Neurology) | $168,412.55 |
| Anitha Rao | Mishawaka, IN | Neurology (Psychiatry & Neurology) | $162,962.26 |
| Justin Moon | Denver, CO | Neurology (Psychiatry & Neurology) | $161,224.50 |
Prescribed Leqembi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.